Literature DB >> 9699671

Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.

R G Fenton1, J A Hixon, P W Wright, A D Brooks, T J Sayers.   

Abstract

The ras oncogene plays an important role in the multistep progression to cancer by activation of signal transduction pathways that contribute to aberrant growth regulation. Although many of these effects are cell autonomous, the ras oncogene also regulates the expression of genes that alter host/tumor interactions. We now extend the mechanisms through which ras promotes tumor survival by demonstrating that oncogenic Ras inhibits expression of the fas gene and renders Ras-transformed cells resistant to Fas-induced apoptosis. A panel of Ras-transformed clones exhibited a marked inhibition in fas mRNA and Fas cell surface expression as compared with untransformed parental cell lines. Fas expression was induced by culture in the presence of IFN-gamma + tumor necrosis factor alpha; however, the maximal level attained in Ras transformants was approximately 10-fold below the level of untransformed cells. Whereas untransformed cells were sensitive to apoptotic death induced by cross-linking surface Fas (especially after cytokine treatment), Ras-transformed cells were very resistant to Fas-induced death even under the most stringent assay conditions. To demonstrate that this resistance was mediated by oncogenic Ras and not secondary genetic events, pools of Ras-transformed cells were generated using a highly efficient retroviral transduction technique. Transformed pools were assayed 6 days after infection and demonstrated a marked decrease in fas gene expression and Fas-mediated apoptosis. Oncogenic Ras did not promote general resistance to apoptosis, because ectopic expression of a fas cDNA in Ras-transformed cells restored sensitivity to Fas-induced apoptosis. These data indicate that oncogenic Ras inhibits basal levels of expression of the fas gene, and although cytokine signal transduction pathways are functional in these cells, the level of surface Fas expression remains below the threshold required for induction of apoptosis. These data identify a mechanism by which Ras-transformed cells may escape from host-mediated immune destruction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699671

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

Review 1.  Serrated adenoma of the colorectum: a lesion with teeth.

Authors:  Jeremy R Jass
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.

Authors:  H Roelofs; M C Mostert; K Pompe; G Zafarana; M van Oorschot; R J van Gurp; A J Gillis; H Stoop; B Beverloo; J W Oosterhuis; C Bokemeyer; L H Looijenga
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 3.  Apoptosis and colorectal cancer.

Authors:  A J M Watson
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

4.  Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma.

Authors:  John J Liang; Sadir Alrawi; Dongfeng Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

Authors:  J Peli; M Schröter; C Rudaz; M Hahne; C Meyer; E Reichmann; J Tschopp
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

6.  Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.

Authors:  J P Medema; J de Jong; L T Peltenburg; E M Verdegaal; A Gorter; S A Bres; K L Franken; M Hahne; J P Albar; C J Melief; R Offringa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

Review 7.  Chemoprevention of melanoma.

Authors:  Marie-France Demierre; Glenn Merlino
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

8.  RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.

Authors:  Thomas Sebastian; Peter F Johnson
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

9.  Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells.

Authors:  J C Symes; C Siatskas; D H Fowler; J A Medin
Journal:  Cancer Gene Ther       Date:  2008-12-19       Impact factor: 5.987

Review 10.  My approach to serrated polyps of the colorectum.

Authors:  T Higuchi; J R Jass
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.